Malihe Sadat Moayed1, Amir Vahedian-Azimi2, Golshan Mirmomeni3, Farshid Rahimi-Bashar4, Keivan Goharimoghadam5, Mohamad Amin Pourhoseingholi6, Mohsen Abbasi-Farajzadeh7, Mostafa Hekmat8, Thozhukat Sathyapalan9, Paul C Guest10, Amirhossein Sahebkar11,12,13,14. 1. Trauma Research Center, Nursing Faculty, Baqiyatallah University of Medical Sciences, Tehran, Iran. 2. Trauma Research Center, Nursing Faculty, Baqiyatallah University of Medical Sciences, Tehran, Iran. amirvahedian63@gmail.com. 3. Hearing Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. 4. Anesthesia and Critical Care Department, Hamadan University of Medical Sciences, Hamadan, Iran. 5. Internal Medicine, Shariati hospital, Tehran University of Medical Sciences, Tehran, Iran. 6. Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, ShahidBeheshti University of Medical Sciences, Tehran, Iran. 7. Marine Medicine Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. 8. Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. 9. Academic Diabetes, Endocrinology and Metabolism, Hull York Medical School, University of Hull, Hull, UK. 10. Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazil. 11. Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir. 12. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir. 13. Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland. sahebkara@mums.ac.ir. 14. Halal Research Center of IRI, FDA, Tehran, Iran. sahebkara@mums.ac.ir.
Abstract
AIM: Patients with confirmed COVID-19 infection can develop several psychological consequences. Epidemiological data on mental health and psychological disorder inpatients infected with COVID-19 pneumonia are not available in Iranian patients. The purpose of this study was to evaluate the anxiety, stress, and depression of patients with COVID-19. MATERIAL AND METHODS: This cross-sectional survey was conducted in 2020. All confirmed patients with COVID-19 were included in the study by census sampling. Assessment of depression, stress, and anxiety was performed using the DASS-21 questionnaire. All statistical analyses were performed using R version 3.5.1. RESULTS: The questionnaires were completed by 221 patients with COVID-19 infection (204 males, 17 females). The mean age was 45.90 ± 7.73 years. Our results indicated that the mean scores of depression and anxiety were at "extremely severe" levels, while stress levels were "severe." The prevalence of "extremely severe" symptoms of depression and anxiety was 54.29% and 97.29%, respectively. The prevalence of severe stress was 46.61%. CONCLUSION: In this study, patients infected with COVID-19 reported severe and extremely severe experience psychological distress. Further studies should focus on the combined use of psychological and molecular biomarker testing to increase accuracy. Overall, the findings demonstrate the necessity of special intervention programs for the confirmed patients with emerging infectious disease COVID-19 to promote mental health needs.
AIM: Patients with confirmed COVID-19infection can develop several psychological consequences. Epidemiological data on mental health and psychological disorder inpatients infected with COVID-19 pneumonia are not available in Iranian patients. The purpose of this study was to evaluate the anxiety, stress, and depression of patients with COVID-19. MATERIAL AND METHODS: This cross-sectional survey was conducted in 2020. All confirmed patients with COVID-19 were included in the study by census sampling. Assessment of depression, stress, and anxiety was performed using the DASS-21 questionnaire. All statistical analyses were performed using R version 3.5.1. RESULTS: The questionnaires were completed by 221 patients with COVID-19infection (204 males, 17 females). The mean age was 45.90 ± 7.73 years. Our results indicated that the mean scores of depression and anxiety were at "extremely severe" levels, while stress levels were "severe." The prevalence of "extremely severe" symptoms of depression and anxiety was 54.29% and 97.29%, respectively. The prevalence of severe stress was 46.61%. CONCLUSION: In this study, patientsinfected with COVID-19 reported severe and extremely severe experience psychological distress. Further studies should focus on the combined use of psychological and molecular biomarker testing to increase accuracy. Overall, the findings demonstrate the necessity of special intervention programs for the confirmed patients with emerging infectious diseaseCOVID-19 to promote mental health needs.
Authors: Stephanie Veazie; Brenda Lafavor; Kathryn Vela; Sarah Young; Nina A Sayer; Kathleen F Carlson; Maya E O'Neil Journal: J Affect Disord Rep Date: 2022-02-10
Authors: Leilanie Apostol-Nicodemus; Ian Kim B Tabios; Anna Guia O Limpoco; Gabriele Dominique P Domingo; Ourlad Alzeus G Tantengco Journal: J Clin Med Date: 2022-09-05 Impact factor: 4.964